Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01276613
Recruitment Status : Active, not recruiting
First Posted : January 13, 2011
Last Update Posted : July 11, 2017
Information provided by (Responsible Party):
M.D. Anderson Cancer Center